Literature DB >> 29655817

The influence of insurance status on treatment and outcomes in oral cavity cancer: an analysis on 46,373 patients.

J Y Shin1, J K Yoon2, A K Shin3, A Z Diaz2.   

Abstract

The purpose of this study was to determine the influence of insurance status on treatment and outcomes in oral cavity cancer. Patients were identified in the National Cancer Database (NCDB). Data were collected and analyzed using χ2 tests, Kaplan-Meier methods, and multivariable Cox regression models. Those uninsured or on Medicaid were more likely to be younger (P<0.001), minority race (P<0.001), have a lower median household income (P<0.001), lower educational attainment (P<0.001), not undergo primary resection (P<0.001), present with higher T (P<0.001),N (P<0.001), and M (P<0.001) stage of disease, and have a higher tumor grade (P<0.001). On univariate analysis, those with private insurance had significantly better overall survival than those uninsured (hazard ratio (HR) 1.481), under Medicaid (HR 2.006), or on Medicare (HR 1.921). On multivariable Cox regression analysis, insurance status remained an independent prognosticator even after accounting for multiple demographic, socioeconomic, treatment, and clinicopathological factors. These data suggest that insurance status is associated with treatment and outcomes in patients with oral cavity cancer. Being uninsured or on Medicaid was found to be associated with a higher risk of a poorer prognosis when compared to private insurance, and the data suggest the need to expand comprehensive medical coverage and optimize access to adequate medical care in vulnerable patient populations.
Copyright © 2018 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NCDB; insurance status; oral cavity cancer; outcomes; socioeconomic status

Mesh:

Year:  2018        PMID: 29655817     DOI: 10.1016/j.ijom.2018.03.022

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  6 in total

1.  Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes.

Authors:  Nicholas R Lenze; Douglas Farquhar; Siddharth Sheth; Jose P Zevallos; Jeffrey Blumberg; Catherine Lumley; Samip Patel; Trevor Hackman; Mark C Weissler; Wendell G Yarbrough; Adam M Zanation; Andrew F Olshan
Journal:  Laryngoscope       Date:  2020-11-10       Impact factor: 3.325

2.  Relationship between the Human Development Index and its Components with Oral Cancer in Latin America.

Authors:  Brenda Yuliana Herrera-Serna; Edith Lara-Carrillo; Victor Hugo Toral-Rizo; Regiane Cristina do Amaral; Raul Alberto Aguilera-Eguía
Journal:  J Epidemiol Glob Health       Date:  2019-12

3.  Socioeconomic indicators and economic investments influence oral cancer mortality in Latin America.

Authors:  Aldelany Ramalho Freire; Deborah Ellen Wanderley Gomes Freire; Elza Cristina Farias de Araújo; Fernanda Campos de Almeida Carrer; Gilberto Alfredo PuccaJúnior; Simone Alves de Sousa; Edson Hilan Gomes de Lucena; Yuri Wanderley Cavalcanti
Journal:  BMC Public Health       Date:  2021-02-18       Impact factor: 3.295

4.  Evaluation of Patient-Reported Delays and Affordability-Related Barriers to Care in Head and Neck Cancer.

Authors:  Nicholas R Lenze; Jeannette T Bensen; Laura Farnan; Siddharth Sheth; Jose P Zevallos; Wendell G Yarbrough; Adam M Zanation
Journal:  OTO Open       Date:  2021-12-12

5.  Decreased overall survival in black patients with HPV-associated oropharyngeal cancer.

Authors:  Siddharth Sheth; Douglas R Farquhar; Nicholas R Lenze; Angela Mazul; Paul Brennan; Devasena Anantharaman; Behnoush Abedi-Ardekani; Jose P Zevallos; D Neil Hayes; F Olshan
Journal:  Am J Otolaryngol       Date:  2020-10-22       Impact factor: 1.808

6.  Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma.

Authors:  Nicholas R Lenze; Douglas R Farquhar; Siddharth Sheth; Jose P Zevallos; Catherine Lumley; Jeffrey Blumberg; Samip Patel; Trevor Hackman; Mark C Weissler; Wendell G Yarbrough; Andrew F Olshan; Adam M Zanation
Journal:  Oral Oncol       Date:  2021-06-20       Impact factor: 5.972

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.